山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (2): 28-31.doi: 10.6040/j.issn.1673-3770.1.2016.08

• column_cn • 上一篇    下一篇

肿瘤标志物检测在甲状腺癌临床诊治中的意义

邱杰,孙彦   

  1. 青岛大学附属医院耳鼻咽喉头颈外科, 山东 青岛 266003
  • 收稿日期:2016-03-10 出版日期:2016-04-16 发布日期:2016-04-16

Role of tumor marker in the diagnosis and treatment of thyroid carcinoma.

QIU Jie, SUN Yan   

  1. Department of Otolaryngology Head And Neck Surgery, Affiliated Hospital Of Qingdao University, Qingdao 266003, Shandong, China
  • Received:2016-03-10 Online:2016-04-16 Published:2016-04-16

关键词: 治疗, 肿瘤标志物, 甲状腺癌, 诊断

Key words: Tumor marker, Thyroid carcinoma, Diagnosis, Treatment

中图分类号: 

  • R736.1
[1] Swierniak M, Wojcicka A, Czetwertynska M, et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma[J]. J Clin Endocrinol Metab., 2013, 98(8):1401-1409.
[2] Network CGAR: Integrated genomic characterization of papillary thyroid carcinoma[J]. Cell, 2014, 159(3):676-690.
[3] Qiu J, Zhang W W, Xia Q S, et al. RNA Sequencing identifies crucial genes in papillary thyroid carcinoma(PTC)progression[J]. Exp Mol Pathol, 2016, 100(1):151-159.
[4] Kushchayeva Y, Jensen K, Burman J K, et al. Repositioning therapy for thyroid cancer: new insights on established medications[J]. Endocr Relat Cancer, 2014, 21(3):183-194.
[5] Essig G F Jr, Porter K, Schneider D, et al. Fine needle aspiration and medullary thyroid carcinoma:the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone[J]. Endocr Pract, 2013, 19(6):920-927.
[6] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3):157-164.
[7] Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, et al. Predictive factors that influence the course of medullary thyroid carcinoma[J]. Int J Clin Oncol, 2014, 19(3):445-451.
[8] Barbet J, Campion L, Kraeber-Bodere F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubing-times in patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab, 2005, 90(11):6077-6084.
[9] Bugalho M J, Santos J R, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement[J]. J Surg Oncol, 2005, 91(1):56-60.
[10] Camacho C P, Lindsey S C, Melo M C, et al. Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests[J]. Thyroid, 2013, 23(3):308-316.
[11] Wimalawansa S J. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma[J]. J Bone Miner Res, 1993, 8(4):467-473.
[12] Yap N S-J,Maher R, Learoyd D C. Any detectable thyroglobulin in lymph node biopsy washouts suggests local recurrence in differentiated thyroid cancer[J]. Endocr Connect, 2014, 3(1):150-155.
[13] Milas M, Bsrbosa G F, Mitchell J, et al. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer[J]. Ann Surg Oncol, 2009, 16(2):473-480.
[14] Ersoz S, Sert H, Yandi M, et al. The significance of galectin-3 expression in immunocytochemical evaluation of thyroid fine needle aspiration cytology[J]. Pathol Oncol Res, 2008, 14(4):457-460.
[15] Paunovic I, Isic T, Havelka M, et al. Combined immunohistochemistry for thyroid peroxidase, Galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors[J]. APMIS, 2012, 120(5):368-379.
[16] Ma H,Xu S, Yan J, et al. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination[J]. Pol J Pathol, 2014, 65(3):202-209.
[17] Liu Z, Li X, Shi L, et al. Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma[J]. Int J Clin Exp Med, 2014, 7(8):2304-2308.
[18] Calangiu C M, Simionescu C E, Stepan A E, et al. The expression of CK19, vimentin and E-cadherin in differentiation thyroid carcinomas[J]. Rom J Morphol Embryol, 2014, 55(3):919-925.
[19] Tian X, Cong M, Zhou W, et al. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer[J]. J Int Med Res, 2008, 36(4):699-703.
[1] 吴静,刘业海. 头颈部鳞状细胞癌的靶向治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 97-102.
[2] 沈勤峰,沈小燕,朱荣强,蒋斐斐,郎军添. 鼻内镜下中鼻甲功能性部分切除治疗慢性鼻窦炎76例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 82-85.
[3] 朱明娟,邢凯,亢泽峰,刘健. 甲状腺相关性眼病的诊断及治疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 110-113.
[4] 王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74.
[5] 代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112.
[6] 刘义平,林远超. 负压引流防治腮腺术后涎瘘112例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 65-67.
[7] 陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22.
[8] 张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.
[9] 覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26.
[10] 吴湘萍. 患者管理方式对变应性鼻炎舌下含服粉尘螨滴剂疗效的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 68-72.
[11] 王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106.
[12] 钟建文,刘大波,罗向前,黄振云,仇书要,程超,杨李强,易新华,曾锦鸿. 可穿戴设备在儿童阻塞性睡眠呼吸暂停诊断中的应用[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 30-33.
[13] 高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42.
[14] 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86.
[15] 李俏丽,李超,王薇,蔡永聪,孙荣昊,周雨秋,税春燕, 黄璐,涂静. 术后放化疗后复发并侵及侧颅底的原发性腮腺鳞状细胞癌一例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 87-88.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 王晓晔,尤建强,邱建鹤. 舌下特异性免疫治疗对变应性鼻炎患者生活质量的影响[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 13 -15 .
[2] 朱文燕,金新,佘万东,马永驰. 突发性聋30例精神心理状况分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 50 -52 .
[3] 周慧, 黄雪琴, 胡俊丽, 姚俊, 张月飞, 江枫. 黄芩苷对鼻咽癌化疗期间激素使用影响的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 30 -32 .
[4] 赵学林 . 鼻内镜下治疗老年性鼻出血84例[J]. 山东大学耳鼻喉眼学报, 2007, 21(3): 266 -266 .
[5] 苏法仁,丁静华,刘新刚,薄琳. 软带骨锚式助听器在先天性双侧小耳畸形患者中的应用[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 74 -75 .
[6] 赵露,谢国丽,王艳玲. 玻璃体腔注射雷珠单抗对湿性年龄相关性黄斑变性患者眼血流动力学的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 101 -104 .
[7] 陶钰,张士玺,柴雪荣,申家泉. 青光眼患者生存质量及其影响因素的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 84 -86 .
[8] 梁送民1,郭永伟2综述,赵霞1审校. 便携式睡眠监测仪对阻塞性睡眠呼吸暂停综合征的诊断价值[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 22 -25 .
[9] 江朝勇, 蔡永明, 殷亚磊. 耳后药物注射治疗突发性聋32例[J]. 山东大学耳鼻喉眼学报, 2014, 28(6): 18 -20 .
[10] 庞文会1,时光刚1,时蕾1,王和峰2,王小婷1,韩杰1,李建峰1,王海波1. 调节性T细胞与IgE、IL-4、IL-5在变应性鼻炎小鼠和鼻用激素抗炎中的实验研究[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 29 -33 .